Skip to content
Subscriber Only

Glaxo Chief Says Consumer Health Unit Can Exist on Its Own

  • Witty sees no rationale for spinoff of vaccines business
  • Drugmaker will keep focus on organic growth, not M&A
Video player cover image

GSK’s Witty Sees EU Member Benefits

Updated on

GlaxoSmithKline Plc’s consumer health unit could be “conceptually thought about on its own,” Chief Executive Officer Andrew Witty said as he considers investors’ demands to break up the U.K. drugmaker.

The unit, which makes Sensodyne toothpaste and the painkiller Panadol, probably won’t be spun off in the next 18 months, Witty said in a Bloomberg Television interview with Hans Nichols and Jonathan Ferro in Davos, Switzerland.